Related Experiment Videos
Congenital dyserythropoietic anaemia type II: a case study
E De Laere1, A Louwagie, A Criel
1Laboratorium Hematologie, A.Z. Sint-Jan, Ruddershove 10, B-8000 Brugge.
Acta Clinica Belgica
|August 3, 2002
Summary
This study identifies congenital dyserythropoietic anaemia (CDA) type II in a 13-year-old girl presenting with chronic anaemia. Key findings include splenomegaly, specific bone marrow abnormalities, and a positive Ham's test, confirming the diagnosis.
Area of Science:
- Hematology
- Genetics
- Pediatrics
Background:
- Congenital dyserythropoietic anaemia (CDA) comprises a group of inherited disorders affecting red blood cell production.
- CDA type II, also known as the CDAN1 gene-related disorder, is characterized by specific morphological and biochemical abnormalities.
Observation:
- A 13-year-old female presented with chronic anemia, splenomegaly, and mild microcytic anemia.
- Bone marrow examination revealed numerous bizarre and binucleate normoblasts, indicative of ineffective erythropoiesis.
- The patient's red blood cells exhibited a markedly increased expression of the 'i' antigen.
Findings:
- The acidified serum lysis test (Ham's test) was positive when performed with normal sera, a hallmark of CDA type II.
- The combination of clinical features, bone marrow morphology, positive Ham's test, and altered 'i' antigen expression confirmed the diagnosis of CDA type II.
Implications:
- This case highlights the diagnostic utility of Ham's test and 'i' antigen expression in identifying CDA type II.
- Accurate diagnosis is crucial for appropriate management and genetic counseling in patients with congenital dyserythropoietic anemia.
- Further research into the genetic basis and pathomechanisms of CDA type II can lead to improved therapeutic strategies.